Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
暂无分享,去创建一个
C. Bergmann | M. Hennerici | K. Beyreuther | H. Runz | K. Fassbender | T. Bertsch | T. Hartmann | P. Keller | M. Stroick | D. Lütjohann | K. von Bergmann | D. Lütjohann | T. Hartmann | M. Simons | C. Bergmann | S. Kühl | P. Keller | M. Hennerici | K. Fassbender | K. Beyreuther | M. Simons | M. Stroick | H. Runz | S. Kühl | T. Bertsch | K. von Bergmann | K. Beyreuther | K. Bergmann | Konrad Beyreuther | Klaus Fassbender | Mikael Simons | Mark Stroick | Dieter Lütjohann | Patrick Keller | Heiko Runz | Sandra Kühl | Thomas Bertsch | Tobias Hartmann
[1] H Jick,et al. Statins and the risk of dementia , 2000, The Lancet.
[2] G. Celesia,et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.
[3] Rong Wang,et al. Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.
[4] Min Xu,et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] L. Lannfelt,et al. Quantification of Alzheimer Amyloid β Peptides Ending at Residues 40 and 42 by Novel ELISA Systems , 2000, Molecular medicine.
[6] P. George-Hyslop. Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.
[7] Guorong Xu,et al. Comparative regulation of hepatic sterol 27-hydroxylase and cholesterol 7alpha-hydroxylase activities in the rat, guinea pig, and rabbit: effects of cholesterol and bile acids. , 1999, Metabolism: clinical and experimental.
[8] M. Brown,et al. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Keyomarsi,et al. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[10] D J Stephens,et al. The role of cholesterol in the biosynthesis of beta-amyloid. , 1999, Neuroreport.
[11] T. Hartmann,et al. Intracellular biology of Alzheimer’s disease amyloid beta peptide , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[12] T. Mizuno,et al. Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells. , 1998, Biochimica et biophysica acta.
[13] B. Strooper,et al. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Kodama,et al. βAPP γ‐secretase and SREBP site 2 protease are two different enzymes , 1998 .
[15] J. Laguna,et al. Influence of lipid profile and fatty acid composition on the oxidation behavior of rat and guinea pig low density lipoprotein. , 1998, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[16] Hugo Vanderstichele,et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.
[17] S. Paul,et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.
[18] L. Schad,et al. Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging , 1997, Molecular Psychiatry.
[19] R. Doms,et al. Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.
[20] C. Masters,et al. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.
[21] Y. Ihara,et al. Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42* , 1997, The Journal of Biological Chemistry.
[22] E. Ikonen,et al. Functional rafts in cell membranes , 1997, Nature.
[23] C. Masters,et al. Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Hofman,et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.
[25] G. Thorgeirsson,et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. , 1996, Archives of internal medicine.
[26] C. Masters,et al. The beta‐amyloid domain is essential for axonal sorting of amyloid precursor protein. , 1996, The EMBO journal.
[27] Hans Förstl,et al. Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.
[28] J. Pitha,et al. Intracellular Trafficking of Cholesterol Monitored with a Cyclodextrin* , 1996, The Journal of Biological Chemistry.
[29] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[30] C. Masters,et al. Alzheimer's Disease βA4 Protein Release and Amyloid Precursor Protein Sorting Are Regulated by Alternative Splicing* , 1996, The Journal of Biological Chemistry.
[31] Nobuhiro Suzuki,et al. Amyloids and Are Generated Intracellularly in Cultured Human Neurons and Their Secretion Increases with Maturation (*) , 1996, The Journal of Biological Chemistry.
[32] B. de Strooper,et al. Production of intracellular amyloid‐containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. , 1995, The EMBO journal.
[33] S. Younkin. Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .
[34] J. Slattery,et al. Scandinavian simvastatin study (4S) , 1994, The Lancet.
[35] J. Stengård,et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.
[36] Stephen W. Scheff,et al. Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.
[37] J. Trojanowski,et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[39] D. Selkoe,et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.
[40] D. Selkoe,et al. Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.
[41] F. Czubayko,et al. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. , 1991, Journal of lipid research.
[42] Y. Horsmans,et al. Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor). , 1990, Pharmacology & toxicology.
[43] R. Tilvis,et al. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. , 1990, American journal of epidemiology.
[44] J. Volpe,et al. Cell Cycle‐Specific Requirement for Mevalonate, but Not for Cholesterol, for DNA Synthesis in Glial Primary Cultures , 1987, Journal of neurochemistry.
[45] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[46] J. L. Robinson,et al. Hypocholesteremia induced by orotic acid: dietary effects and species specificity. , 1984, The Journal of nutrition.
[47] C. West,et al. The density profile and cholesterol concentration of serum lipoproteins in domestic and laboratory animals. , 1982, Comparative biochemistry and physiology. B, Comparative biochemistry.
[48] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.